Mitalee Dharwadkar
Family Medicine · Muscatine, IANPI 1437599701
Payments from drug & device makers
Across 81 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$238
- AbbVie$151
- Mylan Specialty L.p.$136
- Novartis$69
- Merck$60
- Biohaven Pharmaceutical Holding Company Ltd.$55
- plus $504 from 19 others
What the payments were for
- Food & beverage$1,213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $238 |
| AbbVie(2 entities) | 9 | $151 |
| Mylan Specialty L.p. | 9 | $136 |
| Novartis | 5 | $69 |
| Merck | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Astellas Pharma US Inc | 4 | $55 |
| GSK | 3 | $51 |
| Bayer | 3 | $43 |
| Lilly USA, LLC | 3 | $42 |
| Boehringer Ingelheim | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Covis Pharma GmbH | 3 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Johnson & Johnson | 2 | $23 |
| Amarin Pharma, Inc. | 1 | $18 |
| Insulet Corporation | 1 | $16 |
| Amgen | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
| Eisai Inc. | 1 | $12 |
How this compares
$1,213 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 108 | $67,703 |
| OzempicSemaglutide | 34 | $45,643 |
| JardianceEmpagliflozin | 21 | $24,069 |
| NucyntaTapentadol Hcl | 17 | $23,244 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 26 | $22,164 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $13,048 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,525 |
| Pregabalin | 69 | $9,664 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $7,876 |
| Humalog Kwikpen U-100Insulin Lispro | 51 | $6,944 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $5,826 |
| Duloxetine Hcl | 43 | $5,721 |
| Paroxetine Hcl | 21 | $4,852 |
| Levetiracetam | 41 | $2,890 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 90 | $2,679 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKAnoro Ellipta, Breo Ellipta, Trelegy Ellipta | $51 | $46,73772 claims |
| Novo NordiskOzempic | $238 | $45,64334 claims |
| Boehringer IngelheimJardiance | $41 | $24,06921 claims |
| AstraZenecaSymbicort | $13 | $7,87621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Muscatine
- Leslie George PaulsenMuscatine$136K
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.